Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: Comparison with protein kinase C

Circulation Research

Volumn 88, Issue 8, 2001, Pages 774-779

  Chrissobolis, Sophocles ^a   Sobey, Christopher G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cerebral artery; Hypertension; Protein kinase C; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALPHOSTIN C; FASUDIL; N(G) NITROARGININE METHYL ESTER; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RHO KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BLOOD VESSEL TONE; BRAIN BLOOD VESSEL; BRAIN CIRCULATION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTENSION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REGULATORY MECHANISM;

EID: 0035957574     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh0801.090441     Document Type: Article

References (36)

1. Kimura K. Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J. Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphalase by rho and rho-assooiatcd kinase (rho-kinase). Science. 1996;273:24S-248.
2. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J. Physiol. 2000;522:177-185.
3. Numaguchi K, Eguchi S. Yamakawa T, Motley ED, Inagami T. Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments,. Cric Res. 1999;85:5-11.
4. 2+ sensitization by PKC and rho proteins in ovine cerebral arteries: effects of artery size and age. Am J Physiol. 1998;275:H930-H939.
5. Harder DR, Smeda J, Lombard J. Enhanced myogenic depolarization in hypertensive cerebral arterial muscle. Cric Res. 1985;57:319-322.
6. Gebremedhin D, Fenoy FJ, Harder DR, Roman RJ. Enhanced vascular tone in the rat vasculalure of spontaneously hypertensive rats. Hypertension. 1990;16:648-654.
7. Falcone JC, Granger HJ, Meininger GA. Enhanced myogenic activation in skeletal muscle arterioles from spontaneously hypertensive rats. Am J Physiol. 1993;265:H1847-H1855.
8. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Cire Res 1990;66:8-17.
9. Heistad DD, Baumbach GL, Kitazono T, Faraci FM. Effects of hypertension on cerebral blood vessels. Hypertens Res. 1993;16:225-231.
10. Hoshijima M, Sah VP, Wang Y, Chien KR, Brown JH. The low molecular weight GTPase rho regulates myofibril formation and organization in neonatal rat ventricular myocytes: involvement of rho kinase. J Biol Chem. 1998;273:7725-7730.
11. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990-994.
12. Osol G. Mechanotransduction by vascular smooth muscle. J. Vase Res. 1995;32:275-292.
13. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev. 1999;79:387-423.
14. 2+ sensitization of myosin phosphorylation and force in guinea pig ileum. J. Physiol. 2000; 522:33-49.
15. Seusholtz TM, Majumdar M, Brown JH. Rho as a mediator of G proteincoupled receptor signaling. Mol Pharmacol. 1999;55:949-956.
16. Ono-Suito N, Niki I, Hiduka H. H-series protein kinase inhibitors and potential clinical applications. Pharmacol Ther. 1999;82:123-131.
17. Shimokawa H, Seto M, Katsumata N, Amano M. Kozai T, Yamawaki T, Kuwata K, Kandabashi T. Egashira K, Ikegaki T, Asano T, Kaibuchi K, Takeshita A. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res. 1999;43:1029-1039.
18. Sato M, Tani E, Fujikawa H, Kaibuchi K. Involvement of rho-kinase- mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res. 2000;87:195-200.
19. Mayhan WG. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. Am J Physiol. 1990;259: H1455-H1462.
20. Kitazono T, Heistad DD, Faraci FM. ATP-sensitive potassium channels in the basilar artery during chronic hypertension. Hypertension. 1993;22: 677-681.
21. Kitazono T, Heistad DD, Faraci FM. Enhanced responses of the basilar artery to activation of endothelin-B receptors in stroke-prone spontaneously hypertensive rats. Hypertension. 1995;25(pt l):490-494.
22. Sobey CG, Moffatt JD, Cocks TM. Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation. Stroke. 1999;30:1933-1941.
23. Salaices M, Balfagon G, Arribas S. de Sagarra MR, Marin J. Effects of phorbol 12,13-dibutyrate on the vascular tone and on norepinephrine- and potassium-induced contractions of cat cerebral arteries. J Pharmacol Exp Ther. 1990;255:66-73.
24. Sugawa M, Koide T, Naitoh S, Takalo M, Matsui T, Asano T. Phorbol 12,13-diacetate-indueed contraction of the canine basilar artery: role of protein kinase C. J Cereb Blood Flow Metab. 1991;11:135-142.
25. Osol G, Laher I, Cipolla M. Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Cric Res. 1991; 68:359-367.
26. +] of phorbol ester-induced arteriolar constriction in piglets. Am J Physiol. 1992;263: H1455-H1459.
27. Murray MA, Faraci FM, Heistad DD. Role of protein kinase C in constrictor responses of the rat basilar artery in vivo. J Physiol. 1992:445: 169-179.
28. Murray MA, Faraci FM, Heistad DD. Signal transduction pathways in constriction of the basilar artery in vivo. Hypertension. 1992;19:739-742.
29. 2+-sensitization of smooth muscle. FEBS Lett. 1998;440: 183-187.
30. Murray MA, Faraci FM, Heistad DD. Effect of protein kinase C inhibitors on endothelin- and vasopressin-induced constriction of the rat basilar artery. Am J Physiol. 1992;263:H1643-H1649.
31. Hill MA, Falcone JC, Meininger GA, Evidence for protein kinase C involvement in arteriolar myogenic reactivity. Am J Physiol. 1990;259: H1586-H1594.
32. Osol G, Laher I, Kelley M. Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am J Physiol. 1993; 265:H415-H420.
33. 2+ signalling: problems and pitfalls. Trends Pharmacol Sci. 1998:19: 370-375.
34. Goldstein JL, Brown JS. Regulation of the mevalonate pathway. Nature. 1990;343:425-430.
35. Packard CJ. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study. Circulation. 1998; 97:1440-1445.
36. Laufs U, Liao JK. Targeting rho in cardiovascular disease. Circ Res. 2000;87:526-528.